Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Quantifying the adaptive potential of an antibiotic resistance enzyme.

Schenk MF, Szendro IG, Krug J, de Visser JA.

PLoS Genet. 2012 Jun;8(6):e1002783. doi: 10.1371/journal.pgen.1002783. Epub 2012 Jun 28.

2.

Structure-function studies of arginine at position 276 in CTX-M beta-lactamases.

Pérez-Llarena FJ, Cartelle M, Mallo S, Beceiro A, Pérez A, Villanueva R, Romero A, Bonnet R, Bou G.

J Antimicrob Chemother. 2008 Apr;61(4):792-7. doi: 10.1093/jac/dkn031. Epub 2008 Feb 14.

PMID:
18281307
3.

Patterns of Epistasis between beneficial mutations in an antibiotic resistance gene.

Schenk MF, Szendro IG, Salverda ML, Krug J, de Visser JA.

Mol Biol Evol. 2013 Aug;30(8):1779-87. doi: 10.1093/molbev/mst096. Epub 2013 May 15.

4.

Characterization of the global stabilizing substitution A77V and its role in the evolution of CTX-M β-lactamases.

Patel MP, Fryszczyn BG, Palzkill T.

Antimicrob Agents Chemother. 2015 Nov;59(11):6741-8. doi: 10.1128/AAC.00618-15. Epub 2015 Aug 17.

5.

Initial mutations direct alternative pathways of protein evolution.

Salverda ML, Dellus E, Gorter FA, Debets AJ, van der Oost J, Hoekstra RF, Tawfik DS, de Visser JA.

PLoS Genet. 2011 Mar;7(3):e1001321. doi: 10.1371/journal.pgen.1001321. Epub 2011 Mar 3.

6.

The genetic code constrains yet facilitates Darwinian evolution.

Firnberg E, Ostermeier M.

Nucleic Acids Res. 2013 Aug;41(15):7420-8. doi: 10.1093/nar/gkt536. Epub 2013 Jun 10.

7.

Molecular basis for the catalytic specificity of the CTX-M extended-spectrum β-lactamases.

Adamski CJ, Cardenas AM, Brown NG, Horton LB, Sankaran B, Prasad BV, Gilbert HF, Palzkill T.

Biochemistry. 2015 Jan 20;54(2):447-57. doi: 10.1021/bi501195g. Epub 2014 Dec 24.

8.

Mutational events in cefotaximase extended-spectrum beta-lactamases of the CTX-M-1 cluster involved in ceftazidime resistance.

Novais A, Cantón R, Coque TM, Moya A, Baquero F, Galán JC.

Antimicrob Agents Chemother. 2008 Jul;52(7):2377-82. doi: 10.1128/AAC.01658-07. Epub 2008 Apr 28.

9.

Evolutionary trajectories of beta-lactamase CTX-M-1 cluster enzymes: predicting antibiotic resistance.

Novais A, Comas I, Baquero F, Cantón R, Coque TM, Moya A, González-Candelas F, Galán JC.

PLoS Pathog. 2010 Jan 22;6(1):e1000735. doi: 10.1371/journal.ppat.1000735.

10.

Predicting the emergence of antibiotic resistance by directed evolution and structural analysis.

Orencia MC, Yoon JS, Ness JE, Stemmer WP, Stevens RC.

Nat Struct Biol. 2001 Mar;8(3):238-42.

PMID:
11224569
11.

In vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario?

Ripoll A, Baquero F, Novais A, Rodríguez-Domínguez MJ, Turrientes MC, Cantón R, Galán JC.

Antimicrob Agents Chemother. 2011 Oct;55(10):4530-6. doi: 10.1128/AAC.00178-11. Epub 2011 Jul 25.

12.

Network models of TEM β-lactamase mutations coevolving under antibiotic selection show modular structure and anticipate evolutionary trajectories.

Guthrie VB, Allen J, Camps M, Karchin R.

PLoS Comput Biol. 2011 Sep;7(9):e1002184. doi: 10.1371/journal.pcbi.1002184. Epub 2011 Sep 22.

13.

Capturing the mutational landscape of the beta-lactamase TEM-1.

Jacquier H, Birgy A, Le Nagard H, Mechulam Y, Schmitt E, Glodt J, Bercot B, Petit E, Poulain J, Barnaud G, Gros PA, Tenaillon O.

Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):13067-72. doi: 10.1073/pnas.1215206110. Epub 2013 Jul 22.

14.

SHV-129: A Gateway to Global Suppressors in the SHV β-Lactamase Family?

Winkler ML, Bonomo RA.

Mol Biol Evol. 2016 Feb;33(2):429-41. doi: 10.1093/molbev/msv235. Epub 2015 Nov 3.

15.

Natural evolution of TEM-1 β-lactamase: experimental reconstruction and clinical relevance.

Salverda ML, De Visser JA, Barlow M.

FEMS Microbiol Rev. 2010 Nov;34(6):1015-36. doi: 10.1111/j.1574-6976.2010.00222.x. Review.

16.

Distant and new mutations in CTX-M-1 beta-lactamase affect cefotaxime hydrolysis.

Pérez-Llarena FJ, Kerff F, Abián O, Mallo S, Fernández MC, Galleni M, Sancho J, Bou G.

Antimicrob Agents Chemother. 2011 Sep;55(9):4361-8. doi: 10.1128/AAC.00298-11. Epub 2011 Jul 5.

17.

Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240-->Gly.

Bonnet R, Dutour C, Sampaio JL, Chanal C, Sirot D, Labia R, De Champs C, Sirot J.

Antimicrob Agents Chemother. 2001 Aug;45(8):2269-75.

18.

Characterization of ESBLs and associated quinolone resistance in Escherichia coli and Klebsiella pneumoniae isolates from an urban wastewater treatment plant in Algeria.

Alouache S, Estepa V, Messai Y, Ruiz E, Torres C, Bakour R.

Microb Drug Resist. 2014 Feb;20(1):30-8. doi: 10.1089/mdr.2012.0264. Epub 2013 Aug 17.

PMID:
23952363
19.

Detection of CTX-M-14 and TEM-52 extended-spectrum beta-lactamases in fecal Escherichia coli isolates of captive ostrich in Portugal.

Carneiro C, Araújo C, Gonçalves A, Vinué L, Somalo S, Ruiz E, Uliyakina I, Rodrigues J, Igrejas G, Poeta P, Torres C.

Foodborne Pathog Dis. 2010 Aug;7(8):991-4. doi: 10.1089/fpd.2009.0494.

PMID:
20367084
20.

[Identification and expression of blaCTX-M-14 and blaCTX-M-24].

Xiong ZZ, Zhu DM, Wang F, Zhang YY.

Zhonghua Yi Xue Za Zhi. 2004 Sep 2;84(17):1454-9. Chinese.

PMID:
15500745

Supplemental Content

Support Center